ACTA1 and neoplasm: As shown in Figure 6A–a, treatment with SD208 (2 μM) for 14 days strongly reversed the tumor exosomes-induced expression of CAF markers including FAP, α-SMA, N-cadherin and Vimentin in hucMSCs.